The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder (Q39122800)

9 September 2017

title

The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder (English)

1 reference

9 September 2017

Marissa M Caudill

1

1 reference

9 September 2017

Aimee M Hunter

series ordinal

2

1 reference

9 September 2017

Ian A Cook

series ordinal

3

1 reference

9 September 2017

Andrew F Leuchter

series ordinal

4

1 reference

9 September 2017

language of work or name

1 reference

24 September 2014

1 reference

Clinical EEG and Neuroscience

9 September 2017

published in

1 reference

9 September 2017

volume

46

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

277-284

1 reference

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

21 January 2018

The Costs of Depression

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Neuroimaging approaches in mood disorders: technique and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Magnetic resonance imaging and late-life depression: potential biomarkers in the era of personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Prediction of treatment response in major depression: integration of concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Early changes in prefrontal activity characterize clinical responders to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Quantitative EEG in the prediction of antidepressant response to imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Midline and right frontal brain function as a physiologic biomarker of remission in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Relationship between brain electrical activity and cortical perfusion in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Prefrontal changes and treatment response prediction in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Frontal EEG predictors of treatment outcome in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Changes in brain function of depressed subjects during treatment with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Effect of acute antidepressant administration on negative affective bias in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

Imaging of thalamocortical dysrhythmia in neuropsychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1550086314532443

21 January 2018

Identifiers

DOI

10.1177/1550086314532443

1 reference

9 September 2017

1 reference